Chimerix Inc Stock, NASDAQ:CMRX
2505 Meridian Parkway, Suite 100, Durham, North Carolina 27713
United States of America
Number of Employees: 87
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.